BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spaander MCW, Van Buuren HR, Hansen BE, Janssen HLA. Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis: Ascites in patients with portal vein thrombosis. Alimentary Pharmacology & Therapeutics 2010;32:529-34. [DOI: 10.1111/j.1365-2036.2010.04375.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Qi X, Wu F, He C, Fan D, Han G. Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature. European Journal of Gastroenterology & Hepatology 2015;27:77-83. [DOI: 10.1097/meg.0000000000000221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Qi XS, Bai M, He CY, Yin ZX, Guo WG, Niu J, Wu FF, Han GH. Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: An 8-year retrospective single-center study. World J Gastroenterol 2013; 19(42): 7447-7454 [PMID: 24259977 DOI: 10.3748/wjg.v19.i42.7447] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
3 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
5 Karuppasamy K. Utility of cone-beam computed tomography in the assessment of the porto-spleno-mesenteric venous system. Cardiovasc Diagn Ther 2016;6:544-56. [PMID: 28123975 DOI: 10.21037/cdt.2016.11.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Ingviya T, Wasuwanich P, Scheimann AO, Felix G, Laengvejkal P, Vasilescu A, Imteyaz H, Seaberg EC, Karnsakul W. Clinical Predictors of Morbidity and Mortality in Hospitalized Pediatric Patients With Ascites. J Pediatr Gastroenterol Nutr 2021;73:86-92. [PMID: 33633084 DOI: 10.1097/MPG.0000000000003104] [Reference Citation Analysis]
7 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 26.3] [Reference Citation Analysis]
8 Spaander MCW, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FWG, Janssen HLA. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 2013;11:452-9. [DOI: 10.1111/jth.12121] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
9 Karnsakul W, Ingviya T, Seaberg E, Laengvejkal P, Imteyaz H, Vasilescu A, Schwarz KB, Scheimann AO. Ascites in Children: A Single-Center Experience of 27 Years. J Pediatr Gastroenterol Nutr 2017;64:83-8. [PMID: 27050055 DOI: 10.1097/MPG.0000000000001209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
10 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 12.4] [Reference Citation Analysis]
11 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Crawford JM. Vascular disorders of the liver. Clin Liver Dis. 2010;14:635-650. [PMID: 21055687 DOI: 10.1016/j.cld.2010.08.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
13 Llop E, Seijo S. [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis]. Gastroenterol Hepatol 2016;39:403-10. [PMID: 26547613 DOI: 10.1016/j.gastrohep.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
14 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zhou J, Ke L, Yang D, Chen Y, Li G, Tong Z, Li W, Li J. Predicting the clinical manifestations in necrotizing acute pancreatitis patients with splanchnic vein thrombosis. Pancreatology. 2016;16:973-978. [PMID: 27727096 DOI: 10.1016/j.pan.2016.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2018;. [PMID: 29886103 DOI: 10.1016/j.vph.2018.05.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 15.0] [Reference Citation Analysis]